Funding for this research was provided by:
the National Science and Technology Major Project for investigational new drug (2018ZX09201-014)
the Beijing Municipal Science & Technology Commission (No. Z181100001518005)
the University of Macau (MYRG2019-00066-FHS)
Received: 5 August 2021
Accepted: 17 November 2021
First Online: 18 December 2021
: The study protocol was approved by the Ethics Committee at Beijing Anding Hospital, China (2020- Keyan (No. 10)). All participants provided verbal informed consent, whilst their legal guardians gave written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.